Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery
Seizures are a common symptom of craniocerebral diseases, and epilepsy is one of the comorbidities of craniocerebral diseases. However, how to rationally use anti-seizure medications (ASMs) in the perioperative period of craniocerebral surgery to control or avoid seizures and reduce their associated...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-08-01
|
| Series: | Therapeutic Advances in Neurological Disorders |
| Online Access: | https://doi.org/10.1177/17562864221114357 |
| _version_ | 1811320329486729216 |
|---|---|
| author | Shuli Liang Xing Fan Feng Chen Yonghong Liu Binghui Qiu Kai Zhang Songtao Qi Guojun Zhang Jinfang Liu Jianguo Zhang Jun Wang Xiu Wang Ziyang Song Guoming Luan Xuejun Yang Rongcai Jiang Hua Zhang Lei Wang Yongping You Kai Shu Xiaojie Lu Guoyi Gao Bo Zhang Jian Zhou Hai Jin Kaiwei Han Yiming Li Junji Wei Kun Yang Gan You Hongming Ji Yuwu Jiang Yi Wang Zhiguo Lin Yan Li Xuewu Liu Jie Hu Junming Zhu Wenling Li Yongxin Wang Dezhi Kang Hua Feng Tinghong Liu Xin Chen Yawen Pan Zhixiong Liu Gang Li Yunqian Li Ming Ge Xianming Fu Yuping Wang Dong Zhou Shichuo Li Tao Jiang Lijun Hou Zhen Hong |
| author_facet | Shuli Liang Xing Fan Feng Chen Yonghong Liu Binghui Qiu Kai Zhang Songtao Qi Guojun Zhang Jinfang Liu Jianguo Zhang Jun Wang Xiu Wang Ziyang Song Guoming Luan Xuejun Yang Rongcai Jiang Hua Zhang Lei Wang Yongping You Kai Shu Xiaojie Lu Guoyi Gao Bo Zhang Jian Zhou Hai Jin Kaiwei Han Yiming Li Junji Wei Kun Yang Gan You Hongming Ji Yuwu Jiang Yi Wang Zhiguo Lin Yan Li Xuewu Liu Jie Hu Junming Zhu Wenling Li Yongxin Wang Dezhi Kang Hua Feng Tinghong Liu Xin Chen Yawen Pan Zhixiong Liu Gang Li Yunqian Li Ming Ge Xianming Fu Yuping Wang Dong Zhou Shichuo Li Tao Jiang Lijun Hou Zhen Hong |
| author_sort | Shuli Liang |
| collection | DOAJ |
| description | Seizures are a common symptom of craniocerebral diseases, and epilepsy is one of the comorbidities of craniocerebral diseases. However, how to rationally use anti-seizure medications (ASMs) in the perioperative period of craniocerebral surgery to control or avoid seizures and reduce their associated harm is a problem. The China Association Against Epilepsy (CAAE) united with the Trauma Group of the Chinese Neurosurgery Society, Glioma Professional Committee of the Chinese Anti-Cancer Association, Neuro-Oncology Branch of the Chinese Neuroscience Society, and Neurotraumatic Group of Chinese Trauma Society, and selected experts for consultancy regarding outcomes from evidence-based medicine in domestic and foreign literature. These experts referred to the existing research evidence, drug characteristics, Chinese FDA-approved indications, and expert experience, and finished the current guideline on the application of ASMs during the perioperative period of craniocerebral surgery, aiming to guide relevant clinical practice. This guideline consists of six sections: application scope of guideline, concepts of craniocerebral surgery-related seizures and epilepsy, postoperative application of ASMs in patients without seizures before surgery, application of ASMs in patients with seizures associated with lesions before surgery, emergency treatment of postoperative seizures, and 16 recommendations. |
| first_indexed | 2024-04-13T12:57:43Z |
| format | Article |
| id | doaj.art-7f8e3ca577be4671a059a8dc2e54618e |
| institution | Directory Open Access Journal |
| issn | 1756-2864 |
| language | English |
| last_indexed | 2024-04-13T12:57:43Z |
| publishDate | 2022-08-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Neurological Disorders |
| spelling | doaj.art-7f8e3ca577be4671a059a8dc2e54618e2022-12-22T02:46:00ZengSAGE PublishingTherapeutic Advances in Neurological Disorders1756-28642022-08-011510.1177/17562864221114357Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgeryShuli LiangXing FanFeng ChenYonghong LiuBinghui QiuKai ZhangSongtao QiGuojun ZhangJinfang LiuJianguo ZhangJun WangXiu WangZiyang SongGuoming LuanXuejun YangRongcai JiangHua ZhangLei WangYongping YouKai ShuXiaojie LuGuoyi GaoBo ZhangJian ZhouHai JinKaiwei HanYiming LiJunji WeiKun YangGan YouHongming JiYuwu JiangYi WangZhiguo LinYan LiXuewu LiuJie HuJunming ZhuWenling LiYongxin WangDezhi KangHua FengTinghong LiuXin ChenYawen PanZhixiong LiuGang LiYunqian LiMing GeXianming FuYuping WangDong ZhouShichuo LiTao JiangLijun HouZhen HongSeizures are a common symptom of craniocerebral diseases, and epilepsy is one of the comorbidities of craniocerebral diseases. However, how to rationally use anti-seizure medications (ASMs) in the perioperative period of craniocerebral surgery to control or avoid seizures and reduce their associated harm is a problem. The China Association Against Epilepsy (CAAE) united with the Trauma Group of the Chinese Neurosurgery Society, Glioma Professional Committee of the Chinese Anti-Cancer Association, Neuro-Oncology Branch of the Chinese Neuroscience Society, and Neurotraumatic Group of Chinese Trauma Society, and selected experts for consultancy regarding outcomes from evidence-based medicine in domestic and foreign literature. These experts referred to the existing research evidence, drug characteristics, Chinese FDA-approved indications, and expert experience, and finished the current guideline on the application of ASMs during the perioperative period of craniocerebral surgery, aiming to guide relevant clinical practice. This guideline consists of six sections: application scope of guideline, concepts of craniocerebral surgery-related seizures and epilepsy, postoperative application of ASMs in patients without seizures before surgery, application of ASMs in patients with seizures associated with lesions before surgery, emergency treatment of postoperative seizures, and 16 recommendations.https://doi.org/10.1177/17562864221114357 |
| spellingShingle | Shuli Liang Xing Fan Feng Chen Yonghong Liu Binghui Qiu Kai Zhang Songtao Qi Guojun Zhang Jinfang Liu Jianguo Zhang Jun Wang Xiu Wang Ziyang Song Guoming Luan Xuejun Yang Rongcai Jiang Hua Zhang Lei Wang Yongping You Kai Shu Xiaojie Lu Guoyi Gao Bo Zhang Jian Zhou Hai Jin Kaiwei Han Yiming Li Junji Wei Kun Yang Gan You Hongming Ji Yuwu Jiang Yi Wang Zhiguo Lin Yan Li Xuewu Liu Jie Hu Junming Zhu Wenling Li Yongxin Wang Dezhi Kang Hua Feng Tinghong Liu Xin Chen Yawen Pan Zhixiong Liu Gang Li Yunqian Li Ming Ge Xianming Fu Yuping Wang Dong Zhou Shichuo Li Tao Jiang Lijun Hou Zhen Hong Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery Therapeutic Advances in Neurological Disorders |
| title | Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery |
| title_full | Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery |
| title_fullStr | Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery |
| title_full_unstemmed | Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery |
| title_short | Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery |
| title_sort | chinese guideline on the application of anti seizure medications in the perioperative period of supratentorial craniocerebral surgery |
| url | https://doi.org/10.1177/17562864221114357 |
| work_keys_str_mv | AT shuliliang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT xingfan chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT fengchen chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT yonghongliu chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT binghuiqiu chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT kaizhang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT songtaoqi chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT guojunzhang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT jinfangliu chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT jianguozhang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT junwang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT xiuwang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT ziyangsong chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT guomingluan chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT xuejunyang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT rongcaijiang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT huazhang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT leiwang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT yongpingyou chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT kaishu chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT xiaojielu chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT guoyigao chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT bozhang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT jianzhou chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT haijin chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT kaiweihan chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT yimingli chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT junjiwei chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT kunyang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT ganyou chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT hongmingji chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT yuwujiang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT yiwang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT zhiguolin chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT yanli chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT xuewuliu chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT jiehu chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT junmingzhu chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT wenlingli chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT yongxinwang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT dezhikang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT huafeng chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT tinghongliu chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT xinchen chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT yawenpan chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT zhixiongliu chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT gangli chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT yunqianli chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT mingge chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT xianmingfu chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT yupingwang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT dongzhou chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT shichuoli chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT taojiang chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT lijunhou chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery AT zhenhong chineseguidelineontheapplicationofantiseizuremedicationsintheperioperativeperiodofsupratentorialcraniocerebralsurgery |